Enfermedad pulmonar obstructiva crónica: tratamiento de la fase estable y de las exacerbaciones

Álvarez-Sala, 2001, Recomendaciones para la atención al paciente con enfermedad pulmonar obstructiva crónica, Arch Bronconeumol, 37, 269, 10.1016/S0300-2896(01)75089-2 Barberà, 2001, Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica, Arch Bronconeumol, 37, 297, 10.1016/S0300-2896(01)75074-0 Silagy, 1994, Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation, Lancet, 343, 139, 10.1016/S0140-6736(94)90933-4 Hurt, 1997, A comparison of sustained-release bupropion and placebo for smoking cessation, N Engl J Med, 337, 1195, 10.1056/NEJM199710233371703 Pauwels, 2001, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/ WHO global iniciative for chronic obstructive lung disease (GOLD) workshop summary, Am J Respir Crit Care Med, 163, 1256, 10.1164/ajrccm.163.5.2101039 Galán Dávila, 1997, EPOC. Manifestaciones clínicas, diagnóstico y manejo terapéutico, Medicine, 7, 1648 Viejo Bañuelos, 1998, Tratamiento farmacológico e integrado de la EPOC, 161 Montemayor Rubio, 2001, Tratamiento farmacológico en la enfermedad pulmonar obstructiva crónica, 117 Barnes, 1996, New developments in anticholinergic drugs, Eur Respir Rev, 6, 290 Sauleda, 2001, Tratamiento de la enfermedad pulmonar obstructiva crónica, Rev Clin Esp, 201, 417, 10.1016/S0014-2565(01)70866-1 Cazzola, 1999, Should long-acting beta 2-agonists be considered an alternative first choice option for the treatment of stable COPD?, Respir Med, 93, 227, 10.1016/S0954-6111(99)90017-3 Ramsdell, 1995, Use of theophyline in the treatment of COPD, Chest, 107, 206s, 10.1378/chest.107.5_Supplement.206S Ferguson, 2000, Recommendations for the management of COPD, Chest, 117, 23s, 10.1378/chest.117.2_suppl.23S Pauwels, 1999, Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking, N Engl J Med, 340, 1948, 10.1056/NEJM199906243402503 Paggiaro, 1998, Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease, Lancet, 351, 773, 10.1016/S0140-6736(97)03471-5 Burge, 2000, Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial, Br Med J, 320, 1297, 10.1136/bmj.320.7245.1297 Grandjean, 2000, Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double- blind, placebo-controlled clinical trials, Clin Ther, 22, 209, 10.1016/S0149-2918(00)88479-9 1981, Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema, Lancet, 1, 681 1980, Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease, Ann Intern Med, 93, 391, 10.7326/0003-4819-93-3-391 Sánchez Agudo, 1998, Normativa para la indicación y empleo de la oxigenoterapia continuada domiciliaria (OCD), Arch Bronconeumol, 34, 87, 10.1016/S0300-2896(15)30487-7 De Lucas, 2000, Normativa sobre la rehabilitación respiratoria, Arch Bronconeumol, 36, 257, 10.1016/S0300-2896(15)30167-8 Lin, 1996, Comparison between nocturnal nasal positive pressure ventilation combined with oxygen therapy and oxygen monotherapy in patients with severe COPD, Am J Respir Crit Care Med, 154, 353, 10.1164/ajrccm.154.2.8756806 Meecham Jones, 1995, Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD, Am J Respir Crit Care Med, 152, 538, 10.1164/ajrccm.152.2.7633704 1999, The National Emphysema Treatment Trial Research Group. Rationale and design of the national emphysema treatment trial: a prospective randomized trial of lung volume reduction surgery, Chest, 116, 1750, 10.1378/chest.116.6.1750 Hosenpud, 1998, Effect of diagnosis on survival benefit of lung transplantion of end-stage lung disease, Lancet, 351, 24, 10.1016/S0140-6736(97)06405-2 Martínez Rivera, 2001, Manejo de las exacerbaciones de la EPOC, 133 Moreno Fernández, 2001, Enfermedad pulmonar obstructiva crónica. Reagudización, JANO, 60, 2088 Anthonisen, 1987, Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease, Ann Intern Med, 106, 196, 10.7326/0003-4819-106-2-196 Bach, 2001, Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence, Ann Intern Med, 134, 600, 10.7326/0003-4819-134-7-200104030-00016 Añón Elizalde, 2001, Tratamiento y pronóstico de la reagudización grave de la enfermedad pulmonar obstructiva crónica, Rev Clin Esp, 201, 658, 10.1016/S0014-2565(01)70941-1